J4I.F GRAFT POLYMER UK LS -001

Healthcare Machinery Frankfurt Exchange
0.0010 EUR
Close of Nov 12, 2026
0.0010 0.0035
Market cap
EUR 6.81M
P/E
-
P/B
1.37x
ROE
-92.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending May 2026.

Is J4I.F undervalued?

Graham number

The Graham number of GRAFT POLYMER UK LS -001 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

GRAFT POLYMER UK LS -001 fundamental analysis

No fundamental analysis for GRAFT POLYMER UK LS -001 yet.

GRAFT POLYMER UK LS -001 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About GRAFT POLYMER UK LS -001

Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre-clinical stage product consists of SVN-114 for the treatment of post-traumatic …

Full company profile